Molecular bases of endometrial cancer: New roles for new actors in the diagnosis and the therapy of the disease-Reference-Cited by-同舟云学术

Molecular bases of endometrial cancer: New roles for new actors in the diagnosis and the therapy of the disease

Published:2012-07 Issue:2 Volume:358 Page:244-255
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Llauradó Marta,Ruiz Anna,Majem Blanca,Ertekin Tugce,Colás Eva,Pedrola Núria,Devis Laura,Rigau Marina,Sequeiros Tamara,Montes Melania,Garcia Marta,Cabrera Sílvia,Gil-Moreno Antonio,Xercavins Jordi,Castellví Josep,Garcia Angel,Ramón y Cajal Santiago,Moreno Gema,Alameda Francesc,Vázquez-Levin Mónica,Palacios José,Prat Jaime,Doll Andreas,Matías-Guiu Xavier,Abal Miguel,Reventós Jaume

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference109 articles.

1. Molecular determinants of invasion in endometrial cancer;Abal;Clin. Transl. Oncol.,2007

2. ACOG, 2005. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet. Gynecol. 106, 413–25.

3. Aghajanian, C., Sill, M.W., Darcy, K., Greer, B., McMeekin, D.S., Rose, P.G., et al., 2009. A phase II evaluation of bevacizumab in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group (GOG) study. J. Clin. Oncol. 27, 284s (abstract 5531).

4. Endometrial cancer;Amant;Lancet,2005

5. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies;Bansal;Cancer Control,2009

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk prediction model of uterine corpus endometrial carcinoma based on immune-related genes;BMC Women's Health;2024-07-27

2. Advances and Challenges in the Use of Liquid Biopsy in Gynaecological Oncology;2024

3. Applicator-guided proton therapy versus multichannel brachytherapy for vaginal vault irradiation;Physical and Engineering Sciences in Medicine;2023-07-05

4. PPP1R14B is a diagnostic prognostic marker in patients with uterine corpus endometrial carcinoma;Journal of Cellular and Molecular Medicine;2023-02-23

5. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma;Frontiers in Oncology;2023-01-27